+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Clinical Trial Management Systems (CTMS): Global Strategic Business Report

  • PDF Icon

    Report

  • 208 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 1824112

Global Clinical Trial Management Systems (CTMS) Market to Reach $4 Billion by 2030

The global market for Clinical Trial Management Systems (CTMS) estimated at US$1.4 Billion in the year 2022, is projected to reach a revised size of US$4 Billion by 2030, growing at a CAGR of 14% over the analysis period 2022-2030. Enterprise-Wide CTMS, one of the segments analyzed in the report, is projected to record 14.8% CAGR and reach US$2.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the On-Site CTMS segment is readjusted to a revised 12.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $411.1 Million, While China is Forecast to Grow at 13.2% CAGR

The Clinical Trial Management Systems (CTMS) market in the U.S. is estimated at US$411.1 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$684.9 Million by the year 2030 trailing a CAGR of 13.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.1% and 11% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.

Select Competitors (Total 71 Featured) -

  • ArisGlobal LLC
  • BioClinica Inc.
  • Bio-Optronics Inc.
  • DSG Inc.
  • eResearch Technology Inc.
  • IBM Watson Health
  • Medidata Solutions
  • MedNet Solutions
  • Nextrials Inc.
  • Oracle Corp.
  • PAREXEL International Corp.
  • Trial By Fire Solutions LLC
  • Veeva Systems Inc.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Clinical Trial Management Systems (CTMS) Gain Ground
  • Recent Market Activity
  • Benefits Offered by CTMS
  • Global Market Overview
  • Clinical Trial Management Systems Market to Post Explosive Growth
  • Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth
  • Key Players in the CTMS Market
  • Developed Countries Rule the Market
  • Pharmaceutical Firms and CROs to Drive Adoption Rate
  • Noteworthy Transformations in the Global Clinical Trial Sector
  • Clinical Trial Management Systems (CTMS) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Clinical Trial Globalization Surges Demand for CTMS
2. FOCUS ON SELECT PLAYERS
  • ArisGlobal, LLC (USA)
  • BioClinica, Inc. (USA)
  • Bio-Optronics, Inc. (USA)
  • DSG, Inc. (USA)
  • eResearch Technology, Inc. (USA)
  • IBM Watson Health (USA)
  • MedNet Solutions (USA)
  • Medidata Solutions (USA)
  • Nextrials, Inc. (USA)
  • Oracle Corp. (USA)
  • PAREXEL International Corp. (USA)
  • Trial By Fire Solutions, LLC (USA)
  • Veeva Systems, Inc. (USA)
  • Winchester Business Systems (USA)
3. MARKET TRENDS & DRIVERS
  • Surging Global Population Offers Increased Growth Opportunities
  • Increased Spend on R&D - An Important Growth Driver
  • CROs - The Targeted Customers for CTMS
  • Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand
  • CROs Adept with New Technologies to See More Business in Future
  • Rise in Clinical Trial Complexities Propels CTMS Demand
  • Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand
  • Adoption of Digital Technologies Gains Pace
  • Clinical Trial Operators Demand Efficient Data Management Platforms
  • DLB System’s Solution with Data Management Tools
  • Systems Integration Becomes Imperative
  • Technological Innovations Drive Market Growth
  • MC10 Introduces BioStampRC System to Capture Clinical Trial Data
  • UF Health Cancer Center Unveils OnCore® Clinical Trials Management System
  • UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Licensed Enterprise (On-Premise) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for Licensed Enterprise (On-Premise) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Clinical Trial Management Systems (CTMS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for Clinical Trial Management Systems (CTMS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Enterprise-Wide CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for Enterprise-Wide CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for On-Site CTMS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for On-Site CTMS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Web-Based (On-demand) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Web-Based (On-demand) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Cloud (SaaS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Cloud (SaaS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 23: World Historic Review for Large Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 24: World 16-Year Perspective for Large Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 25: World Recent Past, Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 26: World Historic Review for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 27: World 16-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 28: World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 29: World Historic Review for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 30: World 16-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 31: World Recent Past, Current & Future Analysis for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
  • Table 32: World Historic Review for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
  • Table 33: World 16-Year Perspective for Small & Mid-Sized Pharma-Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
  • Table 34: World Clinical Trial Management Systems (CTMS) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
CANADA
JAPAN
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
CHINA
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
EUROPE
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
FRANCE
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
GERMANY
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
ITALY
UNITED KINGDOM
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
REST OF EUROPE
ASIA-PACIFIC
  • Clinical Trial Management Systems (CTMS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ArisGlobal LLC
  • BioClinica Inc.
  • Bio-Optronics Inc.
  • DSG Inc.
  • eResearch Technology Inc.
  • IBM Watson Health
  • Medidata Solutions
  • MedNet Solutions
  • Nextrials Inc.
  • Oracle Corp.
  • PAREXEL International Corp.
  • Trial By Fire Solutions LLC
  • Veeva Systems Inc.

Table Information